A Phase II Study of Guadecitabine (G) with Irinotecan (IRI) Vs Regorafenib or TAS-102 in Metastatic Colorectal Cancer (mcrc) Patients (Pts)
INTERNATIONAL JOURNAL OF CANCER（2024）
Key words
epigenetic therapy,metastatic colon cancer,phase II
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined